Universe Pharma - Bathi resik saben saham sajrone patang kuartal pungkasan UPC

Universe Pharmaceuticals is developing its potential through ESG standards in Chinese medicine distribution and eco-friendly packaging. The annual EPS TTM trend confirms this trajectory, with the current level standing at -100.30. However, premium pricing for phytotherapy is offset by low-cost consumables, while intense local competition in the regions limits the expansion of the pharmacy chain.
UPC (universe-pharmacy.com): rincian analitis lan laporan miturut indikator

This indicator reflects business profitability dynamics, allowing for an assessment of profit generation efficiency per share. By analyzing the annual growth trend of net income per share TTM, an investor identifies the pace of capital scaling. The metric is calculated as the percentage deviation of the current 12-month EPS from the same period last year. For Universe Pharmaceuticals (UPC), the stability of this figure is driven by the traditional pharmacy segment; however, future share price growth depends on the implementation of new biotechnological developments.